S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Revolutionary Device Redefines Cancer Detection (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Revolutionary Device Redefines Cancer Detection (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
China's manufacturing activity contracts for 5th straight month despite policy support
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Revolutionary Device Redefines Cancer Detection (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Revolutionary Device Redefines Cancer Detection (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
China's manufacturing activity contracts for 5th straight month despite policy support
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Revolutionary Device Redefines Cancer Detection (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Revolutionary Device Redefines Cancer Detection (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
China's manufacturing activity contracts for 5th straight month despite policy support
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Revolutionary Device Redefines Cancer Detection (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
Revolutionary Device Redefines Cancer Detection (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
China's manufacturing activity contracts for 5th straight month despite policy support

G Medical Innovations (GMVDW) Competitors

$0.07
0.00 (0.00%)
(As of 02/29/2024 ET)

GMVDW vs. LBPSW, FWRLX, JUPWW, and EYESW

Should you be buying G Medical Innovations stock or one of its competitors? The main competitors of G Medical Innovations include 4D pharma (LBPSW), Fidelity Select Wireless (FWRLX), Jupiter Wellness (JUPWW), and Second Sight Medical Products (EYESW). These companies are all part of the "manufacturing" sector.

G Medical Innovations vs.

G Medical Innovations (NASDAQ:GMVDW) and 4D pharma (NASDAQ:LBPSW) are both manufacturing companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42MN/AN/AN/AN/A
4D pharma$522KN/AN/AN/AN/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled 4D pharma'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
4D pharma Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
G Medical Innovations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
4D pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

G Medical Innovations and 4D pharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
G Medical InnovationsN/AN/A
4D pharmaN/AN/A

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
4D pharma N/A N/A N/A

Summary

G Medical Innovations beats 4D pharma on 1 of the 1 factors compared between the two stocks.


Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDW vs. The Competition

MetricG Medical InnovationsSurgical Appliance & Supplies Manufacturing IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$1.88B$7.51B
Dividend YieldN/AN/A2.51%3.86%
P/E RatioN/AN/A9.7917.76
Price / SalesN/AN/A7.15199.19
Price / CashN/AN/AN/A54.73
Price / BookN/AN/AN/A4.54
Net IncomeN/AN/AN/A$211.39M
7 Day PerformanceN/AN/A0.46%2.65%
1 Month PerformanceN/AN/A0.99%3.82%
1 Year PerformanceN/AN/A10.39%7.99%

G Medical Innovations Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LBPSW
4D pharma
0 of 5 stars
N/AN/AN/A$0.00$522,000.000.00N/A
FWRLX
Fidelity Select Wireless
0 of 5 stars
$11.65
-1.7%
N/AN/A$0.00N/A0.00147,000High Trading Volume
JUPWW
Jupiter Wellness
0 of 5 stars
$0.60
-24.0%
N/A+409.7%$0.00$5.96M0.008News Coverage
Gap Down
EYESW
Second Sight Medical Products
0 of 5 stars
$0.00
flat
N/AN/A$0.00N/A0.00N/A

Related Companies and Tools

This page (NASDAQ:GMVDW) was last updated on 3/1/2024 by MarketBeat.com Staff